Skip to main navigation Skip to search Skip to main content

Enhanced antitumor activity of cucurbitacin B combined with cerulenin in osteosarcoma

  • Zhe Zhang
  • , Ying Shen
  • , Jian Wu
  • , Lin Cai*
  • *Corresponding author for this work
  • Xianning Cent Hosp

Research output: Contribution to journal › Article › peer-review

Abstract

In the present study, the effect of cucurbitacin B and cerulenin combination on osteosarcoma was investigated to develop an effective treatment regimen. The IC50 values of cerulenin and cucurbitacin B combination in the proportion of 1:1, 1:2 and 2:1 were 3.5, 7.2 and 8.6 mu g/mL, respectively. The combination index (CI) values of < 0.95 for inhibition of growth and < 0.93 for inhibition of SENP5 expression clearly indicated synergism between the two. The Q-value for combination of 1 mu g/mL cerulenin and 1 mu g/mL cucurbitacin B was 1.2. AI calculated for tumor tissues treated with a combination of cucurbitacin B and cerulenin (26.2 +/- 8.4%) was higher than that of the tissues treated separately with cucurbitacin B (14.5 +/- 6.8%) or cerulenin (12.6 +/- 7.5%). The AI for untreated tumor tissues was 4.2 +/- 1.5%. Thus, the combination of cucurbitacin B and cerulenin can be a promising regimen in the treatment of osteosarcoma.
Original languageEnglish
Pages (from-to)956-961
Number of pages6
JournalBangladesh Journal of Pharmacology
Volume10
Issue number4
DOIs
StatePublished - Jan 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • cerulenin
  • cucurbitacin B
  • epirubicin
  • peptidase
  • protein SENP5
  • terpenoid
  • unclassified drug
  • antineoplastic activity
  • apoptosis
  • Article
  • cancer combination chemotherapy
  • cancer inhibition
  • controlled study
  • drug potentiation
  • human
  • human cell
  • human tissue
  • IC50
  • in vitro study
  • in vivo study
  • monotherapy
  • osteoblast
  • osteosarcoma
  • osteosarcoma cell line
  • protein expression
  • Cerulenin
  • Cucurbitacin B
  • Osteosarcoma
  • Tumor

Indexed by

  • SCIE
  • Scopus

Fingerprint

Dive into the research topics of 'Enhanced antitumor activity of cucurbitacin B combined with cerulenin in osteosarcoma'. Together they form a unique fingerprint.

Cite this